CHEBI:74545 - acivicin

Main ChEBI Ontology Automatic Xrefs Reactions Pathways Models
ChEBI Name acivicin
Definition An L-α-amino acid that is L-alanine in which the methyl group is replaced by a (5S)-3-chloro-4,5-dihydro-1,2-oxazol-5-yl group. A glutamine analogue antimetabolite, it interferes with glutamate metabolism and several glutamate-dependent synthetic enzymes. It is obtained as a fermentation product of Streptomyces sviceus bacteria.
Stars This entity has been manually annotated by the ChEBI Team.
Supplier Information
Download Molfile XML SDF
Wikipedia License
Waiting for wikipedia content
Read full article at Wikipedia
Formula C5H7ClN2O3
Net Charge 0
Average Mass 178.57400
Monoisotopic Mass 178.01452
InChI InChI=1S/C5H7ClN2O3/c6-3-1-2(11-8-3)4(7)5(9)10/h2,4H,1,7H2,(H,9,10)/t2-,4-/m0/s1
SMILES [H][C@]1(CC(Cl)=NO1)[C@H](N)C(O)=O
Roles Classification
Chemical Role(s): Bronsted base
A molecular entity capable of accepting a hydron from a donor (Bronsted acid).
(via organic amino compound )
Bronsted acid
A molecular entity capable of donating a hydron to an acceptor (Bronsted base).
(via oxoacid )
Biological Role(s): glutamine antagonist
An antagonist that acts on glutamine receptors.
EC (gamma-glutamyltransferase) inhibitor
An EC 2.3.2.* (aminoacyltransferase) inhibitor that interferes with the action of gamma-glutamyltransferase (EC
antimicrobial agent
A substance that kills or slows the growth of microorganisms, including bacteria, viruses, fungi and protozoans.
antileishmanial agent
An antiprotozoal drug used to treat or prevent infections caused by protozoan parasites that belong to the genus Leishmania.
A substance which is structurally similar to a metabolite but which competes with it or replaces it, and so prevents or reduces its normal utilization.
Any intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites.
mouse metabolite
Any mammalian metabolite produced during a metabolic reaction in a mouse (Mus musculus).
(via L-alpha-amino acid )
Application(s): antineoplastic agent
A substance that inhibits or prevents the proliferation of neoplasms.
antileishmanial agent
An antiprotozoal drug used to treat or prevent infections caused by protozoan parasites that belong to the genus Leishmania.
View more via ChEBI Ontology
ChEBI Ontology
Outgoing acivicin (CHEBI:74545) has role antileishmanial agent (CHEBI:70868)
acivicin (CHEBI:74545) has role antimetabolite (CHEBI:35221)
acivicin (CHEBI:74545) has role antimicrobial agent (CHEBI:33281)
acivicin (CHEBI:74545) has role antineoplastic agent (CHEBI:35610)
acivicin (CHEBI:74545) has role EC (γ-glutamyltransferase) inhibitor (CHEBI:74570)
acivicin (CHEBI:74545) has role glutamine antagonist (CHEBI:138931)
acivicin (CHEBI:74545) has role metabolite (CHEBI:25212)
acivicin (CHEBI:74545) is a isoxazoles (CHEBI:55373)
acivicin (CHEBI:74545) is a non-proteinogenic L-α-amino acid (CHEBI:83822)
acivicin (CHEBI:74545) is a organochlorine compound (CHEBI:36683)
(2S)-amino[(5S)-3-chloro-4,5-dihydro-1,2-oxazol-5-yl]acetic acid
INNs Sources
acivicin ChemIDplus
acivicine ChemIDplus
acivicino ChemIDplus
acivicinum ChemIDplus
Synonyms Sources
(α-S,5S)-α-amino-3-chloro-4,5-dihydro-5-isoxazoleacetic acid ChemIDplus
S,5S)-α-amino-3-chloro-2-isoxazoline-5-acetic acid ChemIDplus
Antibiotic AT 125 ChemIDplus
AT 125 ChemIDplus
AT-125 ChemIDplus
NSC 163501 ChemIDplus
NSC-163501 ChemIDplus
U 42126 ChemIDplus
U-42,126 ChemIDplus
Manual Xrefs Databases
Acivicin Wikipedia
CPD0-1036 MetaCyc
View more database links
Registry Numbers Types Sources
1074649 Reaxys Registry Number Reaxys
42228-92-2 CAS Registry Number ChemIDplus
Citations Waiting for Citations Types Sources
11478776 PubMed citation Europe PMC
14586123 PubMed citation Europe PMC
2383250 PubMed citation Europe PMC
2894949 PubMed citation Europe PMC
3112985 PubMed citation Europe PMC
3165971 PubMed citation Europe PMC
3710919 PubMed citation Europe PMC
3915184 PubMed citation Europe PMC
6102405 PubMed citation Europe PMC
7026076 PubMed citation Europe PMC
7150366 PubMed citation Europe PMC
8060335 PubMed citation Europe PMC
9829740 PubMed citation Europe PMC
Last Modified
03 November 2017